Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Allopurinol 100mg/5ml oral solution
1001040C0AAAPAP
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 114 |
|
Hydroxychloroquine 200mg/5ml oral suspension
1001030C0AABKBK
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | 104 |
|
Voltarol 75mg/3ml solution for injection ampoules
1001010C0BBACAA
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 103 |
|
Difflam 3% cream
1003020F0BBAAAA
|
Difflam (Topical) | Benzydamine hydrochloride | Musculoskeletal and Joint Diseases | 101 |
|
Preservex 100mg tablets
100101080BBAAAA
|
Preservex | Aceclofenac | Musculoskeletal and Joint Diseases | 101 |
|
Methofill 25mg/0.5ml inj pre-filled syringes
1001030U0BGARBI
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 99 |
|
Methofill 12.5mg/0.25ml inj pre-filled injector
1001030U0BGACCD
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 98 |
|
Allopurinol 300mg/5ml oral suspension
1001040C0AAAXAX
|
Allopurinol (Systemic) | Allopurinol | Musculoskeletal and Joint Diseases | 97 |
|
Brufen 400mg tablets
1001010J0BCABAE
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | 96 |
|
Mefenamic acid 50mg/5ml oral suspension
1001010N0AAABAB
|
Mefenamic acid | Mefenamic acid | Musculoskeletal and Joint Diseases | 95 |
|
Dantrolene 25mg/5ml oral suspension
1002020J0AABHBH
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | 93 |
|
Methofill 17.5mg/0.35ml inj pre-filled injector
1001030U0BGAEBV
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 91 |
|
Tizanidine 2mg/5ml oral suspension
1002020T0AAAJAJ
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | 91 |
|
Methofill 15mg/0.3ml inj pre-filled syringes
1001030U0BGAMBG
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 89 |
|
Nurofen Express 200mg liquid capsules
1001010J0B4AUAA
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 78 |
|
Period Pain Reliever 250mg gastro-resistant tablets
1001010P0BZAAAH
|
Accord (Naproxen) | Naproxen | Musculoskeletal and Joint Diseases | 74 |
|
Methofill 10mg/0.2ml inj pre-filled syringes
1001030U0BGALBF
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 72 |
|
Adcortyl Intra-articular / Intradermal 10mg/1ml inj ampoules
1001022U0BBAAAA
|
Adcortyl (Parenteral) | Triamcinolone acetonide | Musculoskeletal and Joint Diseases | 71 |
|
Arnica montana gel
1003020ADAAAAAA
|
Arnica montana | Arnica montana | Musculoskeletal and Joint Diseases | 70 |
|
Felbinac 3% gel
1003020M0AAAAAA
|
Felbinac | Felbinac | Musculoskeletal and Joint Diseases | 68 |
|
Diclofenac 50mg/5ml oral suspension
1001010C0AABLBL
|
Diclofenac sodium (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 66 |
|
Methofill 22.5mg/0.45ml inj pre-filled injector
1001030U0BGAGBX
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 66 |
|
Tiloket 2.5% gel
100302010BEAAAA
|
Tiloket (Topical) | Ketoprofen | Musculoskeletal and Joint Diseases | 66 |
|
Indometacin 75mg modified-release capsules
1001010K0AAADAD
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 64 |
|
Nurofen Maximum Strength Migraine Pain 684mg caplets
1001010ADBCABAC
|
Nurofen Migraine Pain | Ibuprofen lysine | Musculoskeletal and Joint Diseases | 60 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.